Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

recruiting125%
unknown250%
completed125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_4

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

NCT05924425
unknown

Cumulative Blood Pressure Load and Left Ventricular Mass

NCT05465746
completednot_applicable

Validity of 1BPM for Diagnosis of Hypertension

NCT03147573
unknown

24-hour Ambulatory Blood Pressure Monitoring in Patients With Blood Pressure Above Thresholds in General Practice

NCT03774147

Clinical Trials (4)

Showing 4 of 4 trials
NCT05924425Phase 4

Daridorexant to Treat Insomnia in Patients With Mild Cognitive Impairment and Mild to Moderate Alzheimer Disease

Recruiting
NCT05465746

Cumulative Blood Pressure Load and Left Ventricular Mass

Unknown
NCT03147573Not Applicable

Validity of 1BPM for Diagnosis of Hypertension

Completed
NCT03774147

24-hour Ambulatory Blood Pressure Monitoring in Patients With Blood Pressure Above Thresholds in General Practice

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4